We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAIN:NYSEMain Street Capital Corporation Analysis

Data as of 2026-05-27 - not real-time

$51.22

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Main Street Capital (MAIN) trades at $51.22, well below its 20‑day (≈$53.00) and 50‑day (≈$53.71) simple moving averages, signaling a short‑term bearish bias. The MACD is in a bearish configuration and the 14‑day RSI sits at 43, indicating modest downside momentum, while the price is perched near the identified support level of $48.95. Fundamentally, the stock appears cheap on a price‑to‑earnings basis (PE ≈ 10.8 vs. industry average ≈ 16.6) and offers an attractive dividend yield of 8.56%, but the payout ratio is high at ~90% and operating cash flow is negative, raising sustainability concerns.
Valuation models diverge: a discounted‑cash‑flow estimate suggests a fair value near $9.7, implying the market is pricing in a substantial premium, whereas peer‑relative multiples hint at undervaluation. Leverage is notable, with total debt of $2.54 B and a debt‑to‑equity ratio above 80, and the 30‑day volatility of ~39% adds to the risk profile. Recent news highlights a dividend increase and a strong‑buy upgrade due to a narrowing premium‑to‑NAV, but these signals must be weighed against the technical weakness and cash‑flow constraints.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD and RSI indicating downside momentum
  • High dividend payout ratio with negative operating cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Attractive dividend yield but sustainability concerns
  • Low PE relative to industry offering value potential
  • Elevated leverage and volatility increasing uncertainty

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential NAV re‑rating as premium‑to‑NAV narrows
  • Strong cash‑generating assets reflected in positive free cash flow
  • Value-oriented metrics (low PE, high dividend) appealing for income investors

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin74.86%
P/E Ratio10.8
ROE14.37%
ROA5.58%
Debt/Equity82.11
P/B Ratio1.5
Op. Cash Flow$-163850000
Free Cash Flow$238.9M
Industry P/E16.6

Technical Analysis

TrendBearish
RSI43.2
Support$48.95
Resistance$57.80
MA 20$53.00
MA 50$53.71
MA 200$59.17
MACDBearish
VolumeIncreasing
Fear & Greed Index91.98

Valuation

Fair Value$9.72
Target Price$57.43
Upside/Downside12.12%
GradeOvervalued
TypeValue
Dividend Yield8.56%

Risk Assessment

Beta0.83
Volatility39.03%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.